Author Correction: Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus (Nature Medicine, (2022), 28, 10, (2124-2132), 10.1038/s41591-022-02017-5)

Andreas Mackensen; Fabian Müller; Dimitrios Mougiakakos; Sebastian Böltz; Artur Wilhelm; Michael Aigner; Simon Völkl; David Simon; Arnd Kleyer; Luis Munoz; Sascha Kretschmann; Soraya Kharboutli; Regina Gary; Hannah Reimann; Wolf Rösler; Stefan Uderhardt; Holger Bang; Martin Herrmann; Arif Bülent Ekici; Christian Buettner; Katharina Marie Habenicht; Thomas H. Winkler; Gerhard Krönke; Georg Schett

ArticleOPEN ACCESS

Author Correction: Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus (Nature Medicine, (2022), 28, 10, (2124-2132), 10.1038/s41591-022-02017-5)

Nature Medicine

DOI: 10.1038/s41591-022-02091-9

9Citations

40Readers

Abstract

Correction to: Nature Medicine, published online 15 September 2022. In the version of this article initially published, the middle name of Katharina Marie Habenicht was misspelled (Maria), and has been amended in the HTML and PDF versions of the article.

Cite

CITATION STYLE

APA

Mackensen, A., Müller, F., Mougiakakos, D., Böltz, S., Wilhelm, A., Aigner, M., … Schett, G. (2023, November 1). Author Correction: Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus (Nature Medicine, (2022), 28, 10, (2124-2132), 10.1038/s41591-022-02017-5). Nature Medicine. Nature Research. https://doi.org/10.1038/s41591-022-02091-9

Author Correction: Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus (Nature Medicine, (2022), 28, 10, (2124-2132), 10.1038/s41591-022-02017-5)

Abstract

Cite

Register to see more suggestions